Total Payments
$126,747
2024 Payments
$1,440
Companies
9
Transactions
181
Medicare Patients
219
Medicare Billing
$26,999
Payment Breakdown by Category
Other$112,521 (88.8%)
Travel$10,131 (8.0%)
Food & Beverage$4,095 (3.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $112,521 | 52 | 88.8% |
| Travel and Lodging | $10,131 | 55 | 8.0% |
| Food and Beverage | $4,095 | 74 | 3.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alkermes, Inc. | $43,388 | 49 | $0 (2022) |
| Otsuka America Pharmaceutical, Inc. | $29,135 | 42 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $23,825 | 33 | $0 (2023) |
| ABBVIE INC. | $23,582 | 28 | $0 (2024) |
| Allergan, Inc. | $6,382 | 7 | $0 (2021) |
| Sunovion Pharmaceuticals Inc. | $205.87 | 12 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $170.95 | 7 | $0 (2022) |
| Neurocrine Biosciences, Inc. | $37.72 | 2 | $0 (2022) |
| Lundbeck LLC | $20.26 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,440 | 1 | ABBVIE INC. ($1,440) |
| 2023 | $25,727 | 28 | Teva Pharmaceuticals USA, Inc. ($18,817) |
| 2022 | $5,989 | 17 | Teva Pharmaceuticals USA, Inc. ($5,008) |
| 2021 | $28,126 | 33 | AbbVie Inc. ($15,268) |
| 2020 | $5,883 | 8 | Allergan, Inc. ($3,379) |
| 2019 | $33,759 | 50 | Alkermes, Inc. ($29,923) |
| 2018 | $17,103 | 22 | Otsuka America Pharmaceutical, Inc. ($16,927) |
| 2017 | $8,719 | 22 | Otsuka America Pharmaceutical, Inc. ($8,543) |
All Payment Transactions
181 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,440.00 | General |
| Category: NEUROSCIENCE | ||||||
| 12/19/2023 | ABBVIE INC. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,400.00 | General |
| Category: NEUROSCIENCE | ||||||
| 12/07/2023 | ABBVIE INC. | VRAYLAR (Drug) | Travel and Lodging | In-kind items and services | $136.24 | General |
| Category: NEUROSCIENCE | ||||||
| 12/07/2023 | ABBVIE INC. | VRAYLAR (Drug) | Travel and Lodging | In-kind items and services | $17.50 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $21.99 | General |
| Category: PSYCHIATRY | ||||||
| 09/26/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: PSYCHIATRY | ||||||
| 07/26/2023 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: Neurology | ||||||
| 07/26/2023 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Travel and Lodging | Cash or cash equivalent | $1,199.65 | General |
| Category: Neurology | ||||||
| 07/26/2023 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $75.05 | General |
| Category: Neurology | ||||||
| 07/25/2023 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: Neurology | ||||||
| 07/25/2023 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Travel and Lodging | Cash or cash equivalent | $1,079.52 | General |
| Category: Neurology | ||||||
| 07/25/2023 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $91.78 | General |
| Category: Neurology | ||||||
| 06/07/2023 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: Neurology | ||||||
| 06/07/2023 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Travel and Lodging | Cash or cash equivalent | $168.99 | General |
| Category: Neurology | ||||||
| 06/07/2023 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Neurology | ||||||
| 06/07/2023 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Travel and Lodging | Cash or cash equivalent | $9.00 | General |
| Category: Neurology | ||||||
| 06/02/2023 | ABBVIE INC. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,440.00 | General |
| Category: NEUROSCIENCE | ||||||
| 05/06/2023 | Teva Pharmaceuticals USA, Inc. | — | Food and Beverage | In-kind items and services | $68.93 | General |
| 05/06/2023 | Teva Pharmaceuticals USA, Inc. | — | Travel and Lodging | In-kind items and services | $30.36 | General |
| 05/06/2023 | Teva Pharmaceuticals USA, Inc. | — | Food and Beverage | In-kind items and services | $29.02 | General |
| 05/06/2023 | Teva Pharmaceuticals USA, Inc. | — | Food and Beverage | In-kind items and services | $29.02 | General |
| 05/06/2023 | Teva Pharmaceuticals USA, Inc. | — | Food and Beverage | In-kind items and services | $26.61 | General |
| 05/05/2023 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,270.00 | General |
| Category: Neurology | ||||||
| 05/05/2023 | Teva Pharmaceuticals USA, Inc. | — | Travel and Lodging | In-kind items and services | $386.35 | General |
| 05/05/2023 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Travel and Lodging | Cash or cash equivalent | $252.36 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 13 | 13 | $9,126 | $1,980 |
| 2022 | 2 | 71 | 201 | $24,970 | $10,014 |
| 2021 | 1 | 62 | 173 | $19,030 | $8,368 |
| 2020 | 2 | 73 | 163 | $20,570 | $6,636 |
Total Patients
219
Total Services
550
Medicare Billing
$26,999
Procedure Codes
8
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 13 | 13 | $9,126 | $1,980 | 21.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 58 | 188 | $20,680 | $8,789 | 42.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 13 | 13 | $4,290 | $1,225 | 28.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 46 | 152 | $16,720 | $7,607 | 45.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 16 | 21 | $2,310 | $761.60 | 33.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 43 | 127 | $13,970 | $5,195 | 37.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 18 | 24 | $2,640 | $746.12 | 28.3% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 12 | 12 | $3,960 | $694.86 | 17.5% |
About Dr. Richard Jaffe, MD
Dr. Richard Jaffe, MD is a Psychiatry healthcare provider based in Philadelphia, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1962448167.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Richard Jaffe, MD has received a total of $126,747 in payments from pharmaceutical and medical device companies, with $1,440 received in 2024. These payments were reported across 181 transactions from 9 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($112,521).
As a Medicare-enrolled provider, Jaffe has provided services to 219 Medicare beneficiaries, totaling 550 services with total Medicare billing of $26,999. Data is available for 4 years (2020–2023), covering 8 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Philadelphia, PA
- Active Since 06/22/2006
- Last Updated 10/11/2010
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1962448167
Products in Payments
- ARISTADA (Drug) $35,256
- VRAYLAR (Drug) $29,964
- ABILIFY MAINTENA (Drug) $29,099
- UZEDY (Drug) $17,998
- LYBALVI (Drug) $8,008
- AUSTEDO (Drug) $3,948
- LATUDA (Drug) $205.87
- INVEGA SUSTENNA (Drug) $170.95
- Aristada 441 mg (Drug) $124.96
- INGREZZA (Drug) $37.72
- REXULTI (Drug) $36.29
- BRINTELLIX (Drug) $20.26
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Philadelphia
Daniel Weintraub, Md, MD
Psychiatry — Payments: $614,211
Psychiatry $614,211
Dr. Michael Thase, Md, MD
Psychiatry — Payments: $418,426
Psychiatry $418,426
Dr. Karl Doghramji, Md, MD
Psychiatry — Payments: $130,409
Psychiatry $130,409
Kyle Kampman, Md, MD
Psychiatry — Payments: $118,739
Psychiatry $118,739
Ramesh Eluri, M.d, M.D
Psychiatry — Payments: $88,982
Psychiatry $88,982
John Lauriello, Md, MD
Psychiatry — Payments: $75,274
Psychiatry $75,274